"Coenzyme Q10 supplementation reduces HF admissions and improves survival: Q-SYMBIO"
Heart May 31
http://www.theheart.org/article/1545585.do
"Some, however, considered the recommendations to alter clinical practice on the basis of this 420-patient clinical trial premature. Dr Sanjay Kaul (Cedars-Sinai Medical Center, Los Angeles), for example, said he wants to reserve judgment on the data until they have stood up against the scrutiny of the peer-review process. He noted that the mortality data were first presented at the meeting of the International Coenzyme Q10 Association last November, but these are yet to be published."